Aridis Pharmaceuticals Inc (NASDAQ:ARDS)
| 0.1791 Delayed Data As of May 26 |  -0.002 / -1.10%Today’s Change | 0.15 Today|||52-Week Range 2.77 | -84.82% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $6.7M |
Company Description
Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using human monoclonal antibodies, or mAbs, to treat infections. The company was founded by Eric J. Patzer and Vu L. Truong on April 24, 2003 and is headquartered in Los Gatos, CA.
Contact Information
Aridis Pharmaceuticals, Inc. 983 University Avenue Los Gatos California 95032 |
Employees
Shareholders
| Other institutional | 9.05% |
| Individual stakeholders | 4.01% |
| Mutual fund holders | 3.07% |
Top Executives
| Vu L. Truong | Director, Chief Executive & Scientific Officer |
| Fred Kurland | Chief Financial Officer |
| Hasan Jafri | Chief Medical Officer |
| Steven M. Chamow | Vice President-Research & Development |
| Lisa Sher | Head-Investor & Public Relations |
